The groundbreaking success of Viagra undeniably revolutionized the medication landscape, but investing in companies strongly reliant on unbranded versions presents a complex picture. Although early profits were significant, the end of patents and the emergence of discounted alternatives have diminished the customer base. Therefore, a thorough analy